Non-compliance with quality requirements was found: too low benzocaine content, exceeding acceptable limits of related substances (including a single unknown impurity), and excessive tablet crumbling in the friability test. Potential effects: reduced treatment efficacy, possible undefined toxicological risk, difficulties in taking crumbled tablets.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Faringan from any batch. Check any packs you have and return them to a pharmacy. In case of doubts or adverse effects, contact a doctor or pharmacist.
Withdrawal of all batches of Faringan from the market throughout the country and prohibition of placing it on the market; the decision was given immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related